89bio Inc (ETNB) — Cash Flow-to-Debt Ratio
Latest as of June 2025:
-1.23x
89bio Inc (ETNB) has a Cash Flow-to-Debt Ratio of -1.23x as of June 2025, meaning its operating cash flow of $-100.42 Million could theoretically repay -1% of its total liabilities ($81.75 Million) in one year. See ETNB net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
-1.23x
Operating CF / Total Liabilities
Operating Cash Flow
$-100.42 Million
USD
Total Liabilities
$81.75 Million
USD
Data as of
Jun 2025
Most recent filing
89bio Inc Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for 89bio Inc across 7 annual periods. Also explore ETNB net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for 89bio Inc (2018–2024)
Year-by-year debt coverage analysis for 89bio Inc. For market capitalisation and broader financial context, see 89bio Inc (ETNB) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.72x | $-367.82 Million | $77.90 Million | ▼ -119.2% |
| 2023 | -2.15x | $-129.19 Million | $59.96 Million | ▼ -19.5% |
| 2022 | -1.80x | $-81.09 Million | $44.99 Million | ▲ +14.4% |
| 2021 | -2.11x | $-76.78 Million | $36.47 Million | ▲ +63.1% |
| 2020 | -5.70x | $-46.24 Million | $8.11 Million | ▼ -25.6% |
| 2019 | -4.54x | $-25.46 Million | $5.61 Million | ▼ -898.4% |
| 2018 | -0.45x | $-12.47 Million | $27.43 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.